企業プロフィール
Zai Lab Limited 株価・ニュース・カタリスト
- ティッカー:
- ZLAB
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- China and listed in the U
株価パフォーマンス
25.64 USD (-1.00%)
終値
最終更新: 2026年8月17日
1.93B USD
時価総額
株価変動の要因
As of Aug 17, 2026, ZLAB closed down 1.00% at $25.64. No new same-company headline was identified in the current news window.
企業概要
事業概要
Zai Lab is a global biopharmaceutical company focused on oncology, infectious disease, and autoimmune disease. Its story combines commercial execution in Asia with a broad development pipeline and international reach.
所在地とセクター分類
Zai Lab is headquartered in China and listed in the U.S. market. It sits in global specialty biopharma with a strong oncology footprint.
ビジネスモデルの特徴
The company generates value through product commercialization, pipeline progress, and strategic partnerships across major therapeutic areas. Investors watch revenue growth, approvals, and portfolio expansion.
バイオ業界での位置付け
Zai Lab occupies a top-tier global biopharma niche. It is more durable than a small-cap biotech name, but pipeline and commercial catalysts still matter a lot.
今後のカタリスト
- Zai Lab’s catalysts are oncology and immunology commercialization, plus any pipeline step that helps the company keep building a broader China-anchored biotech franchise. The stock moves on execution across multiple assets.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。